发明名称 4-ANILINOQUINAZOLINE DERIVATIVE
摘要 <P>PROBLEM TO BE SOLVED: To provide a quinazoline derivative effective for angiogenesis and/or illness related to vascular permeability increase. <P>SOLUTION: The quinazoline derivative is represented by formula (I), wherein R<SP>1</SP>indicates hydrogen or a methoxy; R<SP>2</SP>indicates various substituents such as a methoxy and an ethoxy; and the phenyl group having (R<SP>3</SP>)<SB>2</SB>is selected from the following phenyl groups: 2-fluoro-5-hydroxyphenyl, 4-bromo-2-fluorophenyl, 2,4-difluorophenyl and the like, a production method of the quinazoline derivative and a pharmaceutical composition containing the compound represented by formula (I) or its pharmaceutically acceptable salt as an active ingredient are provided. The compound represented by formula (I) or its pharmaceutically acceptable salt inhibits the function of VEGF (vascular endotherial growth factor), which is a useful feature for treatment of many disease states including cancer and chronic rheumatoid arthritis. <P>COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2010013450(A) 申请公布日期 2010.01.21
申请号 JP20090171068 申请日期 2009.07.22
申请人 ASTRAZENECA UK LTD 发明人 THOMAS ANDREW PETER;HENNEQUIN LAURENT FRANCOIS ANDRE;JOHNSTONE CRAIG
分类号 C07D239/94;A61K31/505;A61K31/517;A61K31/535;A61K31/5377;A61P9/00;A61P9/10;A61P17/02;A61P17/06;A61P27/02;A61P29/00;A61P35/00;A61P43/00;C07D413/04 主分类号 C07D239/94
代理机构 代理人
主权项
地址